In the present study, we demonstrate in the db/db mouse model of type 2 diabetes that upregulation of some profibrotic genes in the kidney was ameliorated upon SGLT2 inhibition, parallel to the effects of metformin. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.